Form 6-K Summary
Registrant: Happiness Biotech Group Limited, although the request metadata identifies Paranovus Entertainment Technology Ltd.; the supplied filing names Happiness Biotech Group Limited.
Reporting period: October 2021; filed October 25, 2021. The filing reports a proposed acquisition and related definitive agreement, not periodic operating results.
Business Context and Transaction
Happiness Fujian, a wholly owned indirect subsidiary, agreed on October 20, 2021 to acquire 70% of Fujian Shennong Jiagu Development Company Limited, a private PRC company engaged in agricultural-product trading and supply-chain management.
- The transaction values 100% of Shennong at RMB103 million, approximately US$16.1 million.
- Consideration for the 70% interest consists of RMB48 million in cash, approximately US$7.5 million, and 4,200,000 ordinary shares of Happiness Biotech.
- The shares are to be issued to the seller or designees under Securities Act Section 4(a)(2) and Regulation D exemptions.
- Closing is subject to required consents and regulatory approvals.
Financial Metrics, Liquidity, and Capitalization
- Happiness Fujian previously paid the seller RMB60 million, approximately US$9.38 million, as an advance under the January 18, 2021 letter of intent.
- The seller is required to return RMB12 million, approximately US$1.9 million, of that advance.
- The filing text provided does not include current or prior-period revenue, profit, cash flow, margins, debt, or liquidity figures for Happiness Biotech.
- Audited financial statements for Shennong and unaudited pro forma condensed consolidated financial statements for Happiness Biotech were filed as Exhibits 99.1 and 99.2, but their contents are not included in the supplied text.
Material Changes, Outlook, and Contingencies
This filing documents the progression from a nonbinding letter of intent to a definitive acquisition agreement. The final consideration differs from the initial LOI framework, which contemplated cash and shares to be determined after negotiation and asset evaluation.
If Shennong’s aggregate net profits for the next three fiscal years are less than RMB45 million, approximately US$7 million, Happiness Fujian may request Mr. Wensheng Liu to repurchase the 70% equity interest for RMB72.1 million in cash, approximately US$11.3 million.
No additional management guidance, operating outlook, financing arrangements, or risk disclosures are provided in the supplied filing text. The transaction remains subject to closing conditions, including regulatory approvals, and involves execution, valuation, integration, and earnings-performance risks.
Key Facts for Investors to Verify
- Whether all required consents and regulatory approvals were obtained and whether the acquisition closed.
- The final number of shares issued, resulting dilution, and the identity of the recipients.
- Receipt and accounting treatment of the RMB12 million advance refund.
- Shennong’s audited historical financial statements and the Company’s pro forma financial impact in Exhibits 99.1 and 99.2.
- Shennong’s actual aggregate net profits over the three-year performance period and the potential applicability of the repurchase right.
- Any subsequent filings clarifying the registrant’s corporate name, transaction completion, consideration, or related-party relationships.